Oura’s recent public S-1 filing, revealing $1.21 billion in revenue for the nine months ended June 30, 2026—a 74% year-over-year increase driven by 3.1 million rings shipped and 5 million paid members—underpins trader sentiment favoring a closing market capitalization above $17.5 billion. Strong membership gross margins near 89%, 85% retention rates, and expectations of nearly $2 billion in full-year 2026 revenue support premium valuations relative to the prior $11 billion private round. A planned September Nasdaq listing targeting over $16 billion, with up to $3 billion in proceeds amid a favorable IPO window for high-growth consumer health names, aligns with the market-implied odds of 41.5% for $20 billion-plus and 25.5% for the $17.5–20 billion bracket. Key catalysts include final pricing details and first-day trading dynamics.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateOura IPO Closing Market Cap
$20B+ 42%
$17.5B–$20B 26%
$15B–$17.5B 22%
$12.5B–$15B 7%
$432,361 Vol.
$432,361 Vol.
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
4%
$12.5B–$15B
7%
$15B–$17.5B
22%
$17.5B–$20B
26%
$20B+
42%
No IPO before January 2027
<1%
$20B+ 42%
$17.5B–$20B 26%
$15B–$17.5B 22%
$12.5B–$15B 7%
$432,361 Vol.
$432,361 Vol.
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
4%
$12.5B–$15B
7%
$15B–$17.5B
22%
$17.5B–$20B
26%
$20B+
42%
No IPO before January 2027
<1%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Binuksan ang Market: May 26, 2026, 12:28 PM ET
Resolver
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Resolver
0x69c47De9D...Oura’s recent public S-1 filing, revealing $1.21 billion in revenue for the nine months ended June 30, 2026—a 74% year-over-year increase driven by 3.1 million rings shipped and 5 million paid members—underpins trader sentiment favoring a closing market capitalization above $17.5 billion. Strong membership gross margins near 89%, 85% retention rates, and expectations of nearly $2 billion in full-year 2026 revenue support premium valuations relative to the prior $11 billion private round. A planned September Nasdaq listing targeting over $16 billion, with up to $3 billion in proceeds amid a favorable IPO window for high-growth consumer health names, aligns with the market-implied odds of 41.5% for $20 billion-plus and 25.5% for the $17.5–20 billion bracket. Key catalysts include final pricing details and first-day trading dynamics.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update


Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong